| DIRECT COMPETITOR COMPARISON | |
| NLTX | BAYRY.PK | BMY | MRK | Industry | | Market Cap: | 36.53M | N/A | 49.80B | 77.41B | 98.96M | | Employees: | 8 | N/A | 35,000 | 55,200 | 65 | | Qtrly Rev Growth (yoy): | N/A | N/A | 4.40% | 1.80% | 19.70% | | Revenue (ttm): | N/A | N/A | 21.14B | 23.37B | 14.01M | | Gross Margin (ttm): | N/A | N/A | 72.39% | 76.36% | 65.68% | | EBITDA (ttm): | -9.10M | N/A | 6.32B | 7.81B | -12.30M | | Oper Margins (ttm): | N/A | N/A | 26.65% | 26.63% | -137.11% | | Net Income (ttm): | -9.28M | N/A | 3.79B | 8.05B | N/A | | EPS (ttm): | -0.375 | N/A | 1.933 | 3.808 | -0.31 | | P/E (ttm): | N/A | N/A | 13.01 | 9.64 | 17.26 | | PEG (5 yr expected): | N/A | 2.73 | 4.61 | 2.21 | 1.28 | | P/S (ttm): | N/A | N/A | 2.36 | 3.32 | 9.45 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 56.85 | 0.53% | 57.54B | 12.40 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 48.18 | 1.69% | 13.93B | 16.12 | | Genzyme Corp. | GENZ | 49.98 | -0.58% | 13.26B | 28.49 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.59 | 0.71% | 41.93B | 18.02 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 50.64 | 0.78% | 9.03B | 1033.47 | | Teva Pharmaceutical Industries Limited | TEVA | 54.01 | 0.82% | 47.58B | 49.41 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 37.90 | 1.64% | 4.02B | 19.54 | | King Pharmaceuticals Inc. | KG | 11.72 | 0.43% | 2.91B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 17.99 | -1.15% | 5.50B | 110.37 | | Pfizer Inc. | PFE | 18.49 | -0.80% | 149.21B | 15.36 | | Johnson & Johnson | JNJ | 64.36 | 0.31% | 177.58B | 14.06 | | GlaxoSmithKline plc | GSK | 42.75 | 0.73% | 108.37B | 13.49 | | Sanofi-Aventis | SNY | 39.38 | -0.35% | 102.83B | N/A | | Novartis AG | NVS | 55.55 | -0.41% | 126.17B | 16.63 |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | RHHBY.PK | 41.42 | -1.03% | N/A | N/A | | AstraZeneca plc | AZN | 46.30 | 1.49% | 67.13B | 9.30 | | Abbott Laboratories | ABT | 53.78 | -0.85% | 83.18B | 14.57 | | Bristol-Myers Squibb Co. | BMY | 25.14 | -0.08% | 49.80B | 13.01 |
|
| NEWS ON DIRECT COMPETITORS | |
| • | BMY | | [$$] Boom and Bust
Sat 7:37am -
at Barrons.com | | • | BMY | | [$$] Even Better Than Bonds
Sat 7:37am -
at Barrons.com | | • | BMY | | UPDATE - Bristol, Pfizer to seek apixaban approval
Fri 8:44pm -
at Reuters | | • | BMY | | Bristol-Myers Squibb and Mead Johnson Announce Amendment and Extension of Exchange Offer
Fri 8:02pm -
Business Wire | | • | BMY | | ADDING MULTIMEDIA Bristol-Myers Squibb And Pfizer Announce Plans To Submit Regulatory Filing For Apixaban In Europe
Fri 7:35pm -
Business Wire | | • | MRK | | Merck, SPDR S&P 500 Trust: Money Flow Leaders (MRK, SPY)
Fri 4:40pm -
at The Wall Street Journal Online | | • | MRK | | Little Warning, Big Message
Fri 12:24pm -
at Forbes.com | | • | MRK | | S&P Stocks Trading at New 52-Week Highs
Fri 10:20am -
at CNBC | | • | MRK | | FDA Approval Boosts Santarus
Fri 9:32am -
Zacks.com | | • | MRK | | UPDATE - FDA staff suggests liver warning on Merck's Cancidas
Fri 8:45am -
at Reuters | | • | MRK | | Give Your Time, Talents, and Song
Fri 8:00am -
at Minyanville.com | | • | MRK | | Chickenpox vaccine may protect kids from shingles
Fri 12:00am -
at Reuters | | • | BAYRY.PK | | Biotech Stocks: Europe drug stocks rally; Cephalon slides
Mon, Nov 23 -
at MarketWatch | | • | BAYRY.PK | | UK health unit rejects Bayer drug as too expensive
Thu, Nov 19 -
at MarketWatch | | • | BAYRY.PK | | Oculus Wins China Approval for Animal Wound Product
Tue, Nov 17 -
at Seeking Alpha | | • | BAYRY.PK | | Trading Outlook for BioElectronics Corporation Issued by StockPreacher.com
Thu, Nov 12 -
GlobeNewswire | | • | BAYRY.PK | | CEO Interview: Aeolus Pharmaceuticals, Inc. - John L. McManus
Mon, Nov 2 -
Wall Street Transcript | | • | BAYRY.PK | | The World's Top Chemical Companies
Mon, Nov 2 -
at Seeking Alpha | | • | BAYRY.PK | | Bayer Disappoints
Wed, Oct 28 -
Zacks.com | | • | BAYRY.PK | | Bayer Earnings Call scheduled for 10:00 am ET today
Tue, Oct 27 -
CCBN | | | All Headlines for these symbols... |
|
|
|
0.22% Nasdaq 
0.04 (2.88%) 
Competitors
